SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-089617
Filing Date
2024-08-14
Accepted
2024-08-14 16:09:27
Documents
19
Effectiveness Date
2024-08-14

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2420586d1_s8.htm S-8 66178
2 EXHIBIT 4.4 tm2420586d1_ex4-4.htm EX-4.4 96746
3 EXHIBIT 5.1 tm2420586d1_ex5-1.htm EX-5.1 16181
4 EXHIBIT 23.2 tm2420586d1_ex23-2.htm EX-23.2 2494
5 EX-FILING FEES tm2420586d1_ex-filingfees.htm   iXBRL EX-FILING FEES 12556
6 GRAPHIC tm2420586d1_ex5-1img001.jpg GRAPHIC 4479
7 GRAPHIC tm2420586d1_ex5-1img002.jpg GRAPHIC 2864
8 GRAPHIC tm2420586d1_ex4-4img001.jpg GRAPHIC 2414
  Complete submission text file 0001104659-24-089617.txt   335230

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT tm2420586d1_ex-filingfees_htm.xml XML 4569
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281545 | Film No.: 241207719
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)